Doctors may soon have a new array of tools to treat and prevent this age-related vision loss.
Poorly regulated stem cell treatments have blinded some macular degeneration patients. But a new technique is showing therapeutic promise.
Macular degeneration, a progressive, degenerative eye disease, is a leading cause of vision loss in people over 60. Stargardt’s disease, also called juvenile macular degeneration, is a similar illness that typically begins in late childhood. Here five men and women speak about how their vision problems have affected their lives.
AMD is the leading cause of vision loss in people aged 60 and over. Even though it’s a painless condition, it will often affect both eyes, with sufferers losing their central vision.
Last year, a 77-year-old woman traveled to a clinic in Georgia to have stem cells injected in her eyes. She came in hope of a cure—or at least something that could help her macular degeneration, which causes a dark spot to appear in the center of vision.
Macular degeneration comes in two forms: dry and wet. The dry form is milder and usually has no symptoms, but it can degenerate into the wet form, which is characterized by the growth of abnormal blood vessels in the back of the eye, potentially causing blurriness or vision loss in the center of the field of vision.
The best treatment for wet macular degeneration is prevention...
Age-related macular degeneration (AMD) is the main cause of blindness in Australia. One in seven people aged over 50 have some signs of macular degeneration.
You are reading this article because of your macula, which is the part of the eye affected by macular degeneration. The macula is the central part of the retina or back of the eye that allows you to see fine detail.
Current treatments for the so-called wet form of macular degeneration, involving injections inside the eye, are already “very effective” compared with laser treatments, which were used before intravitreal injections, said Dr. Ronald C. Gentile, the surgeon director at the New York Eye and Ear Infirmary of Mount Sinai.
Evidence continues to mount that a drug commonly prescribed for decades to treat a painful bladder condition known as interstitial cystitis (IC) is linked to retinal damage and toxicity.
Age-related macular degeneration is the major cause of blindness in older people, and the culprit in more than half of all cases of blindness in the United States.
There's no cure for the condition, so scientists have been hard at work trying to come up with ways to hold it at bay.
Unfortunately, in most cases, taking the antioxidants lutein and zeaxanthin — commonly sold as over-the-counter supplements for "eye health" — didn't slow the damage to the retina that causes vision loss, according to a new study,
Often diagnosed in childhood or adolescence, Stargardt disease is an inherited form of macular degeneration causing central vision loss. The condition is sometimes referred to as juvenile or early onset macular degeneration.
Despite the fact that the disorder mainly affects older individuals, one 29-year-old suffers from a type of macular degeneration called conrad dystrophy. He’s struggled with partial blindness his entire life.
A new computer algorithm could help physicians predict whether a patient’s macular degeneration will progress within a year’s time.
Age Related Macular Degeneration Alliance International strives to bring knowledge, help and hope to individuals and families around the world affected by AMD.
Dedicated to all visual impairments.
Macular Degeneration Support is a world-wide non-profit public service organization founded by retired educator Dan Roberts. Its mission since 1995 has been to provide information and support for people who are affected by macular degeneration and similar retinal diseases. Known more simply as MD Support, it is based on the Internet and also offers a public awareness program designed to reach people who are without Internet access.
The American Macular Degeneration Foundation (AMDF) is here to help you learn about and live with Age-related Macular Degeneration (AMD), offering you healthy living tips, the latest information, and ways to honor those touched by macular disease, while supporting researchers working to prevent, treat and cure macular degeneration and Stargardt disease.
Learn about what macular degeneration is, its symptoms & risk factors, treatment options and how to live with or care for someone with the disease.
A biomedical research unit dedicated to advancing basic biomedical research into the cellular, molecular, and genetic factors that contribute to the human ocular diseases that are known as macular degeneration.
LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO), and diabetic macular edema (DME).
AMD is the most common form of macular degeneration and develops in older people. There are other rare types of macular degeneration which occur in younger people. AMD can affect anyone. It is the most common cause of severe sight problems (visual impairment) in the UK, and indeed in the developed world.